Vanishing Bile Duct Syndrome Associated with Peripheral T Cell Lymphoma, Not Otherwise Specified, Arising in a Posttransplant Setting

Department of Pathology, University of California San Francisco, San Francisco, CA 94143-0134, USA.
Hepatology (Impact Factor: 11.06). 05/2010; 51(5):1856-7. DOI: 10.1002/hep.23614
Source: PubMed
Download full-text


Available from: Ryan M Gill, Aug 11, 2015
  • Source

    Canadian journal of gastroenterology = Journal canadien de gastroenterologie 07/2011; 25(7):356-7. · 1.98 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Posttransplantation lymphoproliferative diseases (PTLD) are mainly Epstein-Barr virus (EBV)-associated disorders of B-cell origin. Due to the rarity of monomorphic T-cell PTLD (T-PTLD), knowledge about pathogenesis, risk factors, therapy, and prognosis relies predominantly on case reports and small series. Therefore, we aimed to provide an overview and a retrospective analysis of this rare PTLD subtype. Methods: We analyzed all available articles on T-PTLD in the PubMed database as well as in our own databases (Institute of Pathology/Department of Paediatric Haematology and Oncology, Hannover Medical School) from 1988 to 2010. Reevaluated parameters were gender, age, transplanted organ, immunosuppressant regimen, time between transplantation and T-PTLD manifestation, T-PTLD subtype, virus positivity, localization, therapy, and follow-up. Results: A total of 163 cases were evaluated. We found that hematopoietic stem cell transplantation was associated with early-onset T-PTLD, whereas late onset occurred after immunosuppression with steroids and azathioprine without administration of calcineurin inhibitors. The major independent favorable prognostic factors were T-PTLD of the large granular lymphocytic leukemia subtype, young age, and a combination of radiotherapy/radiochemotherapy and reduced immunosuppression, whereas the hepatosplenic T-cell lymphoma subtype and cases with involvement of bone marrow, the central nervous system, or graft had an adverse prognosis. Conclusion: T-PTLD is a heterogeneous group of different aberrant T-cell proliferations and represents a significant complication following transplantation, showing a uniformly poor prognosis.
    Transplantation 01/2013; 95(3). DOI:10.1097/TP.0b013e3182762e07 · 3.83 Impact Factor
  • Source

    Journal of Clinical Oncology 06/2013; 31(20). DOI:10.1200/JCO.2012.46.7787 · 18.43 Impact Factor
Show more